VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IWWM-11 2022 | The role of bispecifics in WM

In this video, Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, briefly discusses the potential role of bispecific antibodies in Waldenström’s macroglobulinemia (WM), highlighting the limited data in this space, and further evaluates the activity of odronextamab in WM and other lymphomas. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Research funding from Seattle Genetics, BMS, Affimed, Regeneron, Takeda, AstraZeneca, Pfizer, ADC Therapeutics to my institution for clinical trials.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter